Institutional Ownership
Coeptis Therapeutics Hldgs I
CUSIP 19207A108COMQ1 2026
13D / 13G Filings
8
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
21.7%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
8 filings · latest Nov 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 5.0% | 1.90M | SEC |
| 2 | Feb 14, 2024 | Armistice Capital, LLC | 13G | 10.0% | 3.52M | SEC |
| 3 | Jan 11, 2024 | Leonite Fund I, LP | 13G | 6.0% | 2.05M | SEC |
| 4 | Feb 15, 2023 | Harraden Circle Investments, LLC | 13G/A | — | — | SEC |
| 5 | Feb 6, 2023 | Hudson Bay Capital Management LP | 13G/A | — | — | SEC |
| 6 | Nov 7, 2022 | Lisa Pharma, LLC | 13G/A | 7.3% | 1.43M | SEC |
| 7 | Nov 7, 2022 | Lena Pharma, LLC | 13G/A | 7.3% | 1.43M | SEC |
| 8 | Nov 7, 2022 | Bull Horn Holdings Sponsor LLC | 13D | 21.7% | 4.88M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Anchor Investment Management, LLC | 7.0K | $78.5K |